The CRC Blueprint

My scientific approach to my own cancer – shared with you.

South Korea

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers

Phase 2 · 220 people · 55 sites in 13 countries · Recruiting now

August 7, 2026
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Phase 2 · 140 people · 48 sites in 8 countries · Recruiting now

August 7, 2026
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer

Phase 1 · randomised · 542 people · 84 sites in 11 countries · Recruiting now

August 7, 2026
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Phase 2 · randomised · 768 people · 105 sites in 10 countries · Recruiting now

August 7, 2026
Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer

Phase 3 · randomised · 236 people · 3 sites in South Korea · Recruiting now

August 7, 2026
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Phase 2 · randomised · 80 people · 76 sites in 12 countries · Recruiting now

August 7, 2026
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer

Phase 2 · randomised · 170 people · 14 sites in 4 countries · Recruiting now

August 7, 2026
Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008).

Phase 2 · randomised · 302 people · 109 sites in 22 countries · Running, not taking new patients

August 7, 2026
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

Phase 2 · 225 people · 53 sites in 11 countries · Recruiting now

August 7, 2026
Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer

Phase 3 · randomised · 901 people · 133 sites in 16 countries · Running, not taking new patients

August 7, 2026